SYNTHESIS AND PRELIMINARY PHARMACOLOGICAL EVALUATION OF 2-BENZYLOXY SUBSTITUTED ARYL KETONES AS 5-HT4 RECEPTOR ANTAGONISTS

被引:18
作者
CLARK, RD
JAHANGIR, A
LANGSTON, JA
WEINHARDT, KK
MILLER, AB
LEUNG, E
BONHAUS, DW
WONG, EHF
EGLEN, RM
机构
[1] SYNTEX INC,INST ANALYT RES,PALO ALTO,CA 94304
[2] SYNTEX INC,INST PHARMACOL,PALO ALTO,CA 94304
关键词
D O I
10.1016/S0960-894X(01)80414-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structural modification of the 2-methoxy group and at the 4-position of the piperidine ring of the 5-HT4 partial agonist 1 led to analogues with increased affinity for the 5-HT4 receptor and loss of agonist activity. Similar modification of 2 resulted in 2-(3,5-dimethoxy)benzyloxy derivatives (23,24,26-28) that were found to be 5-HT4 receptor antagonists with subnanomolar affinity.
引用
收藏
页码:2481 / 2484
页数:4
相关论文
共 7 条
[1]  
BAXTER GS, 1991, N-S ARCH PHARMACOL, V343, P439
[2]   KETONES RELATED TO THE BENZOATE 5-HT4 RECEPTOR ANTAGONIST RS-23597 ARE HIGH-AFFINITY PARTIAL AGONISTS [J].
CLARK, RD ;
JAHANGIR, A ;
LANGSTON, JA ;
WEINHARDT, KK ;
MILLER, AB ;
LEUNG, E ;
EGLEN, RM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (20) :2477-2480
[3]   RS-23597-190 - A POTENT AND SELECTIVE 5-HT4 RECEPTOR ANTAGONIST [J].
EGLEN, RM ;
BLEY, K ;
BONHAUS, DW ;
CLARK, RD ;
HEGDE, SS ;
JOHNSON, LG ;
LEUNG, E ;
WONG, EHF .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (01) :119-126
[4]  
FORD APD, 1993, MED RES REV, P633
[5]   (1-BUTYL-4-PIPERIDINYL)METHYL 8-AMINO-7-CHLORO-1,4-BENZODIOXANE-5-CARBOXYLATE HYDROCHLORIDE - A HIGHLY POTENT AND SELECTIVE 5-HT4 RECEPTOR ANTAGONIST DERIVED FROM METOCLOPRAMIDE [J].
GASTER, LM ;
JENNINGS, AJ ;
JOINER, GF ;
KING, FD ;
MULHOLLAND, KR ;
RAHMAN, SK ;
STARR, S ;
WYMAN, PA ;
WARDLE, KA ;
ELLIS, ES ;
SANGER, GJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (25) :4121-4123
[6]   DEVELOPMENT OF A RADIOLIGAND BINDING ASSAY FOR 5-HT(4)-RECEPTORS IN GUINEA-PIG AND RAT-BRAIN [J].
GROSSMAN, CJ ;
KILPATRICK, GJ ;
BUNCE, KT .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (03) :618-624
[7]  
GROSSMAN CJ, 1994, BRIT J PHARMACOL, V111, P332